Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
Cartisorb® - Glucosamine
Bioiberica Spain flag Spain
Abstract ID:
Range of Glucosamine based pharmaceutical products (capsule,tablets,sachets,) authorized in some countries of Europe or ready to register....
Contact Monica Gomez Navarro
Participants
You
Email me a copy of this message
MECHANISM OF ACTION
Glucosamine acts on cartilage metabolism, increasing proteoglycan synthesis and decreasing aggrecanase activity (aggrecanases 1 and 2) and protease MMP-2, MMP-3, MMP-9 and MMP-13.

CARTISORB - Glucosamine.


A wide range of Glucosamine presentations:


1. Cartisorb capsules 625 mg Glucosamine : Authorized and available for licensing out in: Uk, Sweden, Czeck Republic, Portugal, Romania, Iceland and Bulgaria.


2. Cartisorb tablets 625 mg Glucosamine: CTD Dossier ready for registration


3. Cartisorb sachets 1.5000 mg Glucosamine Sulfate. CTD Dossier ready for registration   


Other optimized formulations and innovative galenic presentations at last stages of development.

FEATURED
Last Updated Sep 2016
Technology Type THERAPEUTIC
Phase of Development REGISTERED / FDA APPROVED / FINISHED PRODUCT
CORPORATION